articleAnnals of OncologyJan 29, 2019BRONZE OA

Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001

OHOmid HamidCRCaroline RobertADAdil DaudFSF. Stephen HodiWHWen‐Jen Hwu

Angeles Clinic and Research Institute · Université Paris-Sud · +23 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

939
total citations
FWCI
52.90
Percentile
100%
References
27
Citations per year

Authors

20

Topics & keywords

Topics
Keywords
  • Medicine
  • Pembrolizumab
  • Expanded access
  • Oncology
  • Melanoma
  • Internal medicine
  • Cancer
  • Immunotherapy
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding